Edition:
United Kingdom

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

22.91CAD
26 Apr 2018
Change (% chg)

-- (--)
Prev Close
$22.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,654,398
52-wk High
$30.56
52-wk Low
$12.25

Select another date:

Wed, Apr 18 2018

BRIEF-U.S. International Trade Commission Says Will Probe Certain Clidinium Bromide-Containing Products After Valeant Pharmaceuticals Filed Complaint -Statement

* U.S. INTERNATIONAL TRADE COMMISSION SAYS WILL PROBE CERTAIN CLIDINIUM BROMIDE-CONTAINING PRODUCTS AFTER VALEANT PHARMACEUTICALS FILED COMPLAINT -STATEMENT Source text for Eikon: Further company coverage:

BRIEF-Valeant Says Joseph Papa's 2017 Total Compensation $4.9 Mln

March 21 Valeant Pharmaceuticals International Inc:

BRIEF-Valeant Announces Launch Of Private Offering Of Senior Notes

March 12 Valeant Pharmaceuticals International Inc:

CANADA STOCKS-TSX tumbles as energy, Valeant shares weigh

Feb 28 Canada's main stock index slumped on Wednesday, pulled lower by energy shares that fell alongside the price of oil and as Valeant Pharmaceuticals tumbled after the company gave a weaker-than-expected revenue forecast. * The Toronto Stock Exchange's S&P/TSX composite index unofficially closed down 228.57 points, or 1.46 percent, at 15,442.58. (Reporting by Leah Schnurr Editing by James Dalgleish)

Valeant says wait one more year for turnaround; shares fall

Valeant Pharmaceuticals , nearly two years into Chief Executive Officer Joseph Papa's turnaround plan, on Wednesday told investors earnings and revenue would drop for one more year, before a projected return to growth in 2019.

Select another date: